Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives
Authors:
Open Access
- 18 May 2026
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Abstract
Neoadjuvant chemotherapy (NAC) is a critical therapeutic strategy for locally advanced breast cancer; however, its clinical utility is constrained by tumorKeywords
Funding Information
- National Natural Science Foundation of China (82172362)
This publication has 157 references indexed in Scilit:
- Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dataMolecular Oncology, 2025
- FDA Perspective on the Regulation of Artificial Intelligence in Health Care and BiomedicineJAMA, 2025
- Translating AI for the ClinicianJAMA, 2024
- Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping reviewCancer Innovation, 2024
- Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer CareJAMA Network Open, 2024
- Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health CareJAMA Network Open, 2023
- Leveraging Large Language Models for Decision Support in Personalized OncologyJAMA Network Open, 2023
- Translatability Analysis of National Institutes of Health–Funded Biomedical Research That Applies Artificial IntelligenceJAMA Network Open, 2022
- Prevalence of Missing Data in the National Cancer Database and Association With Overall SurvivalJAMA Network Open, 2021
- Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy forHER2 (ERBB2)–Positive Breast CancerJAMA Network Open, 2019